HL7 FHIR® Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment)
This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.1.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions 
BC MammaprintRiskScoreInterpretationVS ValueSet
Intepretation of Mammaprint Recurrence Score
| Defining URL: | http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-MammaprintRiskScoreInterpretationVS |
| Name: | MammaprintRiskScoreInterpretationVS |
| Definition: | Intepretation of Mammaprint Recurrence Score |
| Publisher: | The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC) |
| Source Resource | XML / JSON / Turtle |
This value set contains 2 concepts
Expansion based on http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-MammaprintRiskScoreInterpretationCS version 0.1.0
All codes from system http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-MammaprintRiskScoreInterpretationCS
| Code | Display | Definition |
| low_risk | Score between 0.0 and +1.0, meaning a patient has on average a 10% chance that her cancer will recur within 10 years without any additional adjuvant treatment, either hormonal therapy or chemotherapy. | Score between 0.0 and +1.0, meaning a patient has on average a 10% chance that her cancer will recur within 10 years without any additional adjuvant treatment, either hormonal therapy or chemotherapy. |
| high_risk | Score between -1.0 and 0.0, meaning a patient has a 29% chance that her cancer will recur within 10 years without any additional adjuvant treatment, either hormonal therapy or chemotherapy. | Score between -1.0 and 0.0, meaning a patient has a 29% chance that her cancer will recur within 10 years without any additional adjuvant treatment, either hormonal therapy or chemotherapy. |